133 related articles for article (PubMed ID: 3929682)
1. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1985 Jul; 28(1):64-8. PubMed ID: 3929682
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa.
Laverdière M; Gallimore B; Restieri C; Poonia K; Chow AW
Diagn Microbiol Infect Dis; 1994 May; 19(1):39-46. PubMed ID: 7956011
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
Watanakunakorn C; Glotzbecker C
Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.
Blaser J; Stone BB; Zinner SH
Antimicrob Agents Chemother; 1985 Mar; 27(3):343-9. PubMed ID: 3922294
[TBL] [Abstract][Full Text] [Related]
5. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
Van der Auwera P
J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
[TBL] [Abstract][Full Text] [Related]
6. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
Machka K; Dietz R
Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
[TBL] [Abstract][Full Text] [Related]
7. In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Zinner SH; Blaser J
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():1-5. PubMed ID: 3086275
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Baumgärtner M; Müller HP; Wundt W
Arzneimittelforschung; 1983; 33(12):1615-9. PubMed ID: 6320836
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal activity of ceftazidime increased by netilmicin.
LeBel M; Pellerin M; Bergeron MG
Drug Intell Clin Pharm; 1985 Dec; 19(12):932-6. PubMed ID: 3910388
[TBL] [Abstract][Full Text] [Related]
10. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
[TBL] [Abstract][Full Text] [Related]
11. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
[TBL] [Abstract][Full Text] [Related]
12. Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin.
Machka K; Baierl W; Braveny I
Eur J Clin Microbiol; 1982 Aug; 1(4):238-42. PubMed ID: 6217066
[TBL] [Abstract][Full Text] [Related]
13. Interactions of antimicrobial combinations in vitro: the relativity of synergism.
Blaser J
Scand J Infect Dis Suppl; 1990; 74():71-9. PubMed ID: 2129067
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H
Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523
[TBL] [Abstract][Full Text] [Related]
15. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
Digranes A; Dibb WL; Benonisen E; Salveson A
Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of 327 clinical isolates to netilmicin.
Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K
J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
[TBL] [Abstract][Full Text] [Related]
18. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
[TBL] [Abstract][Full Text] [Related]
19. Netilmicin: in vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections.
Bonfiglio G; Scuderi AC; Russo G
Chemotherapy; 2001; 47(2):117-22. PubMed ID: 11173813
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
